Current Market Trend
Procurement & Tenders
Population: 24 million
GDP*: USD 1.349 trillion
Currency: Australian Dollar
The Australian medical equipment industry sector has consistently provided good prospects for U.S. exporters. Australia is the 8th largest export market for U.S. manufacturers of medical technology products and the 3rd largest market in the Asia Pacific region after Japan and China. Australia is a competitive and mature market, and there is demand for a full range of innovative medical equipment. The Australian population generally expects a high standard of medical treatment and there is a continuing need for state-of-the-art medical products. U.S. companies compete with other well-established multinational suppliers in the market.
Successful market entry strategies for Australia have three common elements: understanding the market, selecting the optimal partner, and providing ongoing support to that partner. It is important to gain an understanding of the Australian context for a product or service, its competitors, standards, regulations, sales channels, and applications. Success in the market will require appointing an Australian distributor or establishing a local subsidiary, and setting up a local sales presence. Typically, distributors for medical products will cover the entire country and some may also have a subsidiary office in New Zealand. Given the size of the Australian continent - same size as continental U.S.-, and the distance from other countries, local support and service is important. Most of the criteria American firms use to select distributors are applicable to Australia, with expectations adjusted to the scale of the market given the population of 24 million. Performing due diligence on potential local partners is just as important as in the United States.
Current Market Trends
The Medical Technology Association of Australia reports that the industry had a turnover of approximately US$8.9 billion in 2012 – 2013 (including IVDs and dental equipment). The Australian market for medical technology represents a little less than two percent of the global market. Australia’s spending on healthcare is approximately 9.7 percent of GDP, similar to the United Kingdom and Canada but less than the United States (17 percent).
U.S. medical technology is traditionally well received in Australia due to its perceived high quality. The market is sophisticated, mature, and quick to adopt new healthcare technologies. Importers seek to obtain cost-effective and innovative products that will improve patient outcomes and reduce healthcare costs.
Approximately 80 percent of medical devices and diagnostics used in the market are imports. The three major suppliers are the United States, the European Union and Japan.
Health provision and funding comes from the government (public) and non-government (private) sectors. The Federal and State governments fund approximately 68 percent of total health expenditure and the private sector funds the remaining 32 percent. The private sector is comprised of individuals, private health insurers, and other non-government funding sources. The proportion of total health funding from private health insurance funds is approximately 8 percent. Under Australia’s government-funded healthcare scheme, the Government is the primary purchaser of medical equipment. Depending upon the type of products, public hospitals generally account for approximately 70 percent of purchases of medical equipment, with the remaining 30 percent from the private sector. Prices and volumes are influenced by government healthcare policies and provisions of public healthcare services.
The demand for medical products and healthcare services is expected to grow for all age groups with continuing advances in medical technology, the increasing burden of chronic disease, the ageing population, rising incomes and changing consumer expectations. Australians have one of the longest life expectancies in the world (sixth amongst the OECD countries) and demand will continue to increase as Australia’s ageing population progressively relies on the health system for care.
Opportunities exist for products that provide a significant improvement in clinical outcomes and products with clearly differentiated capabilities. There is also a growing demand for products that lead to faster patient recovery, reduce hospital and rehabilitation costs and alleviate or manage disability and chronic pain. Australia’s aging population will significantly influence the demand for products and products that serve the aging population are likely to experience growth.
The Therapeutic Goods Administration (TGA) regulates the medical equipment industry. There are approximately 48,000 medical devices on the Australian Register of Therapeutic Goods, and 2,000 in vitro diagnostics. Australia’s regulatory framework is based on the International Medical Device Regulators Forum (IMDRF) and European Community guidelines. U.S. exporters must appoint an Australian representative/sponsor to obtain regulatory approval from the TGA. U.S.-manufactured medical devices require EC certification. Alternatively, U.S. manufacturers can apply to the TGA for a Conformity Assessment Certificate. Information is available at www.tga.gov.au
Obtaining reimbursement is important and industry has commented that reimbursement governs the way healthcare is delivered in Australia. The reimbursement process, however, is complex. The Australian Government subsidizes the cost of certain products and services through a range of different funding arrangements including public subsidy through the Pharmaceutical Benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS), and through private health insurance reimbursement of prostheses through the Prostheses List.
Information on the Government’s Health Technology Assessment processes to inform decisions about the registration of health technologies for use in Australia, and the reimbursement provided under these funding programs is available at: http://www.health.gov.au/hta
Information for federal government and state government tenders for the three largest states in Australia is available at:
Department of Health https://www.tenders.gov.au/
NSW Health https://tenders.nsw.gov.au/health/
Health Purchasing Victoria https://www.hpv.org.au/
Queensland Health http://www.health.qld.gov.au/hspl/
AusBiotech 2017, October 25-27, Adelaide, www.ausbiotechnc.org
Medical Technology Association of Australia, www.mtaa.org.au
Medicines Australia, www.medicinesaustralia.com.au
IVD Australia, www.ivd.org.au
Products that serve Australia’s ageing population are likely to experience growth. BMI Research forecasts that the orthopedic and prosthetic market will be the fastest growing sector within the Australian medical device market over the next five years.
The leading underlying causes of death in Australia are coronary heart disease, stroke, dementia (including Alzheimer disease), lung cancer, chronic obstructive pulmonary disease (principally emphysema and chronic bronchitis), breast cancer, prostate cancer, diabetes and colorectal cancer. Although Australians are living longer, they are also increasingly suffering from chronic diseases. Approximately 50 percent of all Australians have one chronic disease and around 20 percent have at least two. These include, cardiovascular disease, cancer, chronic kidney disease, diabetes, mental health, musculoskeletal conditions, oral health and respiratory diseases (including asthma and COPD).
Healthcare spending (including investment) US$82 billion
... as percent of GDP 9.7 %
Hospitals, Procedures, Healthcare Professionals
Number of hospitals
Number of hospital beds
... available beds per capita
4.0 beds per 1,000 population
...of which surgeons
...of which pediatricians
Life expectancy men/women total
82.2 yrs; men 79.8 yrs; women 84.8yrs
4.3 deaths/1,000 live births
Percent of population older than
...caused by [highest disease burden]
coronary heart disease
...caused by [second highest]
Dementia and Alzheimer disease
U.S. Commercial Service Contact Information
Name: Monique Roos
Position: Senior Commercial Specialist
Phone: +61 2 9373 9210
Notice to Visitors!
The link you have chosen will take you to a non-U.S. Government website.
If the page does not appear in 5 seconds, please click this: outside web site
Export.gov is managed by the International Trade Administration and
external links are covered by its website disclaimer statement.
BuyUSA.gov is managed by the International Trade Administration and
external links are covered by its website disclaimer statement.